Lucie Rigolot

6PUBLICATIONS

58CO-AUTHORS

Medical infection agents (incl. prions)Haematological tumoursBiomedical engineering not elsewhere classifiedMedical mycologyGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 21, 2026

Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

|May 15, 2025

Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Dec 12, 2024

S56F UBA1 variant: a VEXAS syndrome subtype that follows its own path.

Jean-Baptiste Rieu, Lucie Rigolot

|Apr 18, 2024

A case of acute megakaryoblastic leukaemia following a mediastinal germ cell tumour.

PierreLuc Mairiniac, Lucie Rigolot, Sarah Bertoli

|Feb 24, 2024

Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts.

Mathias Chea, Lucie Rigolot, Alban Canali

|Nov 21, 2023

Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.

Jerome Tamburini, Sarah Mouche, Clement Larrue

Pageof 1

Frequent Collaborators

Jean-Baptiste Rieu

Mael Heiblig

Nicolas Duployez

Yannick Le Bris

Eric Delabesse

Olivier Kosmider

Alban Canali

Sarah Bertoli

Pierre-Yves Dumas

Sylvain Carras

Frequent Collaborators

Jean-Baptiste Rieu

Mael Heiblig

Nicolas Duployez

Yannick Le Bris